Skip to main content
Caplight Logo









Light Horse Therapeutics

Light Horse Therapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://lighthorsetx.com/

Last Round

Series A

Jan 9, 2025

Total Funding Raised

$62M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Light Horse Therapeutics is a biotechnology company that develops first-in-class small molecule therapeutics using a proprietary function-first gene editing platform to discover novel functional sites on disease-critical targets, with an initial focus on oncology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

small molecule drug discoveryoncology therapeuticsdrug discovery platformprecision genome editingundruggable targetschemical biologyfunctional screeningfirst-in-class drugschemoproteomicsbiotech R&Dcomputational biologydrug discovery pipelinetarget identificationbiotech partnershipnext-gen pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Light Horse Therapeutics Comparables

Compare Light Horse Therapeutics with similar companies based on industry and business-model similarity.

Light Horse Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nexo Therapeutics
87%
Frontier Medicines
81%
Odyssey Therapeutics
79%

Light Horse Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 9, 2025

Key People

Founding team and executive leadership

Markus Renschler

Chief Executive Officer

Executive Team

Light Horse Therapeutics Investors

Notable investors and investment history

Light Horse Therapeutics investors
InvestorRounds
Taiho VenturesSeries A
Versant VenturesSeries A
Mubadala CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 45% MoM.

  • Apr 18, 2026

    Monthly visitors increased 46% MoM.

Light Horse Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Light Horse Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Light Horse Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range38
Year Founded2020
Last FundingJan 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?